Changes in Invitro and ex Vivo Lens Metrology With Daily Wear Contact Lenses
Study Details
Study Description
Brief Summary
The purpose of this study is to evaluate changes in contact lens geometry after lens wear
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
N/A |
Detailed Description
The purpose of this study is to evaluate changes invitro and ex vivo in contact lens geometry in daily lens wear
Study Design
Arms and Interventions
| Arm | Intervention/Treatment |
|---|---|
| Active Comparator: Air Optix Aqua Contact lens material: Lotrafilcon A |
Device: Air Optix Aqua
Contact lens material: Lotrafilcon A
Other Names:
|
| Active Comparator: Biofinity Contact lens material: Comfilcon A |
Device: Biofinity
Contact lens material: Comfilcon A
Other Names:
|
| Active Comparator: Proclear Contact lens material: Omafilcon A |
Device: Proclear
Contact lens material: Omafilcon A
Other Names:
|
| Active Comparator: Acuvue Oasys Contact lens material: Senofilcon A |
Device: Acuvue Oasys
Contact lens material: Senofilcon A
Other Names:
|
| Active Comparator: Acuvue 2 Contact lens material: Etafilcon A |
Device: Acuvue 2
Contact lens material: Etafilcon A
Other Names:
|
| Active Comparator: Purevision Contact lens material: Balafilcon A |
Device: Purevision
Contact lens material: Balafilcon A
Other Names:
|
Outcome Measures
Primary Outcome Measures
- Lens Geometry [1 week]
Secondary Outcome Measures
- Corneal Shape [1 week]
- Conjunctival Staining [1 week]
The conjunctival staining
Eligibility Criteria
Criteria
Inclusion Criteria:
-
• Able to read and comprehend English and give informed consent as demonstrated by signing a record of informed consent;
-
Be at least 18 years old;
-
Willing to comply with the wearing and clinical trial visit schedule as directed by the investigator;
-
Have ocular health findings considered to be "normal" and which would not prevent the participant from safely wearing contact lenses;
-
Has vision correctable to at least 6/12 (20/40) or better at distance in each eye with contact lenses;
-
Be experienced at wearing contact lenses.
Exclusion Criteria:
-
• Any pre-existing ocular irritation, injury or condition (including keratoconus and herpes keratitis) of the cornea, conjunctiva or eyelids that would preclude contact lens fitting and safe wearing of contact lenses;
-
Any systemic disease that adversely affects ocular health
-
An active corneal infection or any active ocular disease that would affect wearing of contact lenses;
-
Use of any topical ocular medication during trial with the exception of saline drops ;
-
Use of or a need for any systemic medication or topical medications which may alter normal ocular findings/are known to affect a participant's ocular health/physiology or contact lens performance
-
Eye surgery within 12 weeks immediately prior to enrolment for this trial;
-
Previous corneal refractive surgery;
-
Contraindications to contact lens wear;
-
Participated or currently enrolled in another clinical trial that may have affected vision or ocular physiology within the previous 2 weeks;
-
Be pregnant (formal testing of pregnancy is not required. A participant's verbal report is sufficient);
-
Worn soft contact lenses 2 calendar days or rigid gas permeable/ orthokeratology lenses 7 calendar days prior.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | Institute for Eye Research | Sydney | New South Wales | Australia | 2052 |
Sponsors and Collaborators
- Alcon Research
Investigators
- Study Chair: Alcon Call Center, Alcon Research
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- M-10-01